Zygomycosis and other rare filamentous fungal infections in solid organ transplant recipients

Transplant International

Volumn 21, Issue 6, 2008, Pages 534-546

  Stelzmueller, Ingrid ^b   Lass Floerl, Cornelia ^b   Geltner, Christian ^c   Graziadei, Ivo ^b   Schneeberger, Stefan ^b   Antretter, Herwig ^b   Mueller, Ludwig ^b   Zelger, Bettina ^d   Singh, Nina ^e   Pruett, Timothy L ^a   Margreiter, Raimund ^b   Bonatti, Hugo ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^c Krankenhaus Natters   (Austria)

^d MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Filamentous fungal infections; Immunosuppression; Posaconazole; Solid organ transplantation; Zygomycosis

Indexed keywords

ALEMTUZUMAB; AMPHOTERICIN B; AZATHIOPRINE; BASILIXIMAB; CASPOFUNGIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DACLIZUMAB; ERYTHROMYCIN; FLUCONAZOLE; ITRACONAZOLE; METRONIDAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VORICONAZOLE;

ABSIDIA; ADULT; AGED; ALTERNARIA ALTERNATA; ARTICLE; CANDIDA GLABRATA; CLINICAL ARTICLE; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CUNNINGHAMELLA; DISEASE COURSE; FEMALE; GRAFT REJECTION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOPROLIFERATIVE DISEASE; MALE; MUCORMYCOSIS; ORGAN TRANSPLANTATION; PETRIELLIDIUM BOYDII; PNEUMONIA; PRIORITY JOURNAL; RISK FACTOR; TRICHODERMA; ZYGOMYCETES;

ADULT; AGED; FATAL OUTCOME; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE; LYMPHOPROLIFERATIVE DISORDERS; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTS; ZYGOMYCOSIS;

EID: 42649085359     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2008.00657.x     Document Type: Article

References (74)

1. Taylor AL, Watson CJ, Bradley JA. Immunosuppressive agents in solid organ transplantation: mechanisms of action and therapeutic efficacy. Crit Rev Oncol Hematol 2005 56 : 23.
2. Bassetti M, Righi E, Bassetti D. Antimicrobial prophylaxis in solid-organ transplantation. Expert Rev Anti Infect Ther 2004 2 : 761.
3. Feng S, Barr M, Roberts J, Oberbauer R, Kaplan B. Developments in clinical islet, liver thoracic, kidney and pancreas transplantation in the last 5 years. Am J Transplant 2006 6 : 1759.
4. Simon DM, Levin S. Infectious complications of solid organ transplantations. Infect Dis Clin North Am 2001 15 : 521.
5. Kalil AC, Dakroub H, Freifeld AG. Sepsis and solid organ transplantation. Curr Drug Targets 2007 8 : 533.
6. Garrido RS, Aguado JM, Díaz-Pedroche C, et al. A review of critical periods for opportunistic infection in the new transplantation era. Transplantation 2006 15 : 82.
7. Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol 2007 45 : 305.
8. Perlroth J, Choi B, Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 2007 45 : 321.
9. Kauffman CA. Fungal infections. Proc Am Thorac Soc 2006 3 : 35.
10. Peleg AY, Husain S, Kwak EJ, et al. Opportunistic infections in 547 organ transplant recipients receiving alemtuzumab, a humanized monoclonal CD-52 antibody. Clin Infect Dis 2007 15 : 44.
11. Silveira FP, Husain S. Fungal infections in solid organ transplantation. Med Mycol 2007 45 : 305.
12. Marik PE. Fungal infections in solid organ transplantation. Expert Opin Pharmacother 2006 7 : 297.
13. Gavalda J, Len O, San Juan R, et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis. 2005 41 : 52.
14. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses 2001 44 : 253.
15. Sampathkumar P, Paya CV. Fusarium infection after solid-organ transplantation. Clin Infect Dis 2001 32 : 1237.
16. Sahi H, Avery RK, Minai OA, et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 2007 26 : 350.
17. Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003 37 : 221.
18. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis 2006 25 : 215.
19. Hammer GS, Bottone EJ, Hirschman SZ. Mucormycosis in a transplant recipient. Am J Clin Pathol 1975 64 : 389.
20. Singh N, Gayowski T, Singh J, Yu VL. Invasive gastrointestinal zygomycosis in a liver transplant recipient: case report and review of zygomycosis in solid-organ transplant recipients. Clin Infect Dis 1995 20 : 617.
21. Almyroudis NG, Sutton DA, Linden P, Rinaldi MG, Fung J, Kusne S. Zygomycosis in solid organ transplant recipients in a tertiary transplant center and review of the literature. Am J Transplant 2006 6 : 2365.
22. Sims CR, Ostrosky-Zeichner L. Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center. Arch Med Res 2007 38 : 90.
23. Vetrone G, Grazi GL, Ercolani G, et al. Successful treatment of rhinomaxillary form of mucormycosis infection after liver transplantation: a case report. Transplant Proc 2006 38 : 1445.
24. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004 17 : 517.
25. Forrest GN, Mankes K. Outcomes of invasive zygomycosis infections in renal transplant recipients. Transpl Infect Dis 2007 9 : 161.
26. Demirag A, Elkhammas EA, Henry ML, et al. Pulmonary Rhizopus infection in a diabetic renal transplant recipient. Clin Transplant 2000 14 : 8.
27. Morris MI, Villmann M. Echinocandins in the management of invasive fungal infections, Part 2. Am J Health Syst Pharm 2006 1 : 63.
28. Vazquez JA, Sobel JD. Anidulafungin: a novel echinocandin. Clin Infect Dis 2006 15 : 43.
29. Patterson TF. The Role of Echinocandins, Extended-spectrum Azoles, and Polyenes to Treat Opportunistic Moulds and Candida. Curr Infect Dis Rep 2006 8 : 442.
30. Trifilio SM, Bennett CL, Yarnold PR, et al. Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy. Transplant 2007 39 : 425.
31. Page RL, Schwiesow J, Hilts A. Posaconazole as salvage therapy in a patient with disseminated zygomycosis: case report and review of the literature. Pharmacotherapy 2007 27 : 290.
32. Petrikkos G, Skiada A. Recent advances in antifungal chemotherapy. Int J Antimicrob Agents 2007 30 : 108.
33. Torres HA, Hachem RY, Chemaly RF, Kontoyiannis DP, Raad II. Posaconazole: a broad-spectrum triazole antifungal. Lancet Infect Dis 2005 5 : 775.
34. Greenberg RN, Mullane K, Van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006 50 : 126.
35. Kauffman CA. Clinical efficacy of new antifungal agents. Curr Opin Microbiol 2006 9 : 483.
36. Herbrecht R. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int J Clin Pract 2004 58 : 612.
37. Saad AH, DePestel DD, Carver PL. Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants. Pharmacotherapy 2006 26 : 1730.
38. Muñoz P, Singh N, Bouza E. Treatment of solid organ transplant patients with invasive fungal infections: should a combination of antifungal drugs be used? Curr Opin Infect Dis 2006 19 : 365.
39. Paul S, Marty FM, Colson YL. Treatment of cavitary pulmonary zygomycosis with surgical resection and posaconazole. Ann Thorac Surg 2006 82 : 338.
40. Costa F, Polini F, Zerman N, Robiony M, Toro C, Politi M. Surgical treatment of Aspergillus mycetomas of the maxillary sinus: review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007 103 : e23.
41. Boata Grosjean P, Weber R. Fungus balls of the paranasal sinuses: a review. Eur Arch Otorhinolaryngol 2007 264 : 461.
42. B. Cohen-Ludmann C, Kerob D, Feuilhade M, et al. Zygomycosis of the penis due to Rhizopus oryzae successfully treated with surgical debridement and a combination of high-dose liposomal and topical amphotericin. Arch Dermatol 2006 142 : 1657.
43. Bonatti H, Goegele H, Tabarelli D, et al. Pseudallescheria boydii infection after liver retransplantation. Liver Transpl 2007 28 : 13.
44. Ladurner R, Brandacher G, Steurer W, et al. Lessons to be learned from a complicated case of rhino-cerebral mucormycosis in a renal allograft recipient. Transpl Int 2003 16 : 885.
45. Bonatti H, Lass-Flörl C, Zelger B, et al. Alternaria alternate soft tissue infection in a forearm transplant recipient. Surg Infect 2007 8 : 539.
46. Margreiter R. Living-donor pancreas and small-bowel transplantation. Langenbecks Arch Surg 1999 384 : 544.
47. Steurer W, Margreiter R, Königsrainer A. Surgical techniques of pancreas transplantation. Acta Chirurgica Austriaca 2001 33 : S8.
48. Lass-Flörl C, Gunsilius E, Gastl G, et al. Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol 2004 42 : 4154.
49. Einsele H, Hebart H, Roller G, et al. Detection and identification of fungal pathogens in blood by using molecular probes. J Clin Microbiol 1997 35 : 1353.
50. Bialek R, Konrad F, Kern J, et al. PCR based identification and discrimination of agents of mucormycosis and aspergillosis in paraffin wax embedded tissue. J Clin Pathol 2005 58 : 1180.
51. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005 41 : 634.
52. Safar A, Marsan J, Marglani O, Al-Sebeih K, Al-Harbi J, Valvoda M. Early identification of rhinocerebral mucormycosis. J Otolaryngol 2005 34 : 166.
53. Lass-Flörl C, Griff K, Mayr A, et al. Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol 2005 131 : 201.
54. Glöckner A, Vehreschild JJ, Cornely OA. Zygomycosis - current epidemiological aspects. Mycoses 2007 50 (Suppl. 1 50.
55. Guarro J, Antolín-Ayala MI, Gené J, Gutiérrez- Calzada J, Nieves-Díez C, Ortoneda M. Fatal case of Trichoderma harzianum infection in a renal transplant recipient. J Clin Microbiol 1999 37 : 3751.
56. Chouaki T, Lavarde V, Lachaud L, Raccurt CP, Hennequin C. Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. Clin Infect Dis 2002 35 : 1360.
57. De Miguel D, Gómez P, González R, et al. Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. Diagn Microbiol Infect Dis 2005 53 : 33.
58. Gallelli B, Viviani M, Nebuloni M, et al. Skin infection due to Alternaria species in kidney allograft recipients: report of a new case and review of the literature. J Nephrol 2006 19 : 668.
59. Miele PS, Levy CS, Smith MA, et al. Primary cutaneous fungal infections in solid organ transplantation: a case series. Am J Transplant 2002 2 : 678.
60. Bhansali A, Bhadada S, Sharma A, et al. Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 2004 80 : 670.
61. Carrafiello G, Laganà D, Nosari AM, et al. Utility of computed tomography (CT) and of fine needle aspiration biopsy (FNAB) in early diagnosis of fungal pulmonary infections. Study of infections from filamentous fungi in haematologically immunodeficient patients. Radiol Med (Torino) 2006 111 : 33.
62. Kim KH, Choi YW, Jeon SC, et al. Mucormycosis of the central airways: CT findings in three patients. J Thorac Imaging 1999 14 : 210.
63. Horger M, Hebart H, Schimmel H, et al. Disseminated mucormycosis in haematological patients: CT and MRI findings with pathological correlation. Br J Radiol 2006 79 : e88.
64. Nosari A, Anghilieri M, Carrafiello G, et al. Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies. Haematologica 2003 88 : 1405.
65. Rimek D, Kappe R. Invasive aspergillosis: results of an 8-year study. Mycoses 2002 45 (Suppl. 3 18.
66. Whitson BA, Maddaus MA, Andrade RS. Thoracoscopic lingulectomy for invasive pulmonary aspergillosis. Am Surg 2007 73 : 279.
67. Gossot D, Validire P, Vaillancourt R, et al. Full thoracoscopic approach for surgical management of invasive pulmonary aspergillosis. Ann Thorac Surg 2002 73 : 240.
68. Caidi M, Kabiri H, Al Aziz S, El Maslout A, Benosman A. Surgical treatment of pulmonary aspergilloma. 278 cases. Presse Med 2006 35 (12 Pt 1) : 1819.
69. Kofteridis DP, Karabekios S, Panagiotides JG, et al. Successful treatment of rhinocerebral mucormycosis with liposomal amphotericin B and surgery in two diabetic patients with renal dysfunction. J Chemother 2003 15 : 282.
70. Stauffer J, Bonatti H, Norman K, et al. Acid blocking medication usage pre and post liver transplantation. Eur Surg 2007 39 : 57.
71. Kontoyiannis DP, Lewis RE. Invasive zygomycosis: update on pathogenesis, clinical manifestations, and management. Infect Dis Clin North Am 2006 20 : 581.
72. Uckay I, Chalandon Y, Sartoretti P, et al. (18,44,45). Invasive zygomycosis in transplant recipients. Clin Transplant 2007 21 : 577.
73. Aslani J, Eizadi M, Kardavani B, et al. Mucormycosis after kidney transplantations: report of seven cases. Scand J Infect Dis 2007 39 : 703.
74. Berger N, Wirmsberger R, Kafka R, et al. Infectious complications following 72 consecutive enteric-drained pancreas transplants. Transpl Int 2006 19 : 549.